Officials Investigating Reports of Thrombocytopenia After COVID-19 Vaccine
Vaccine manufacturers and regulators are examining rare instances of immune thrombocytopenia that have occurred in people who’ve received one of the two authorized mRNA COVID-19 vaccines in the United States, the New York Times reports.
Out of 31 million people who’ve received at least one vaccine dose, nearly 40 cases of thrombocytopenia had been reported to federal health officials as of the end of January, including one fatality. The rate doesn’t appear to be higher than what is seen in the general population.
Hematologists told the Times that such an association is plausible. Thrombocytopenia is a rare side effect of other vaccines, including the measles-mumps-rubella vaccine.